Endoscopic retrograde cholangiopancreatography with rendezvous cannulation reduces pancreatic injury

Table 2 Preoperative demographic characteristics (n = 122)

Group	CV ERCP (n = 41)	RV ERCP (n = 40)	LC control2 (n = 41)	P value
Female	24 (59)	31 (77)	33 (80)	0.06
Age, (yr)	64 ± 14	47 ± 16	50 ± 15	0.003
Body mass index	29 ± 8.1	27 ± 5.9	27 ± 4.9	0.21
Physical status, ASA-score				0.33
Grade 1	12 (29)	20 (50)	20 (49)
Grade 2	23 (56)	16 (40)	16 (39)
Grade 3	6 (15)	4 (10)	5 (12)
Laboratory values, median (25th-75th)
Bilirubin, < 26 mmol/L	28.0 (9.0-97.5)	29.0 (10.0-81.0)	9.0 (7.0-16.0)	1.001
Alkaline phosphatase, < 1.9 μcat/L	3.9 (2.2-5.8)	2.4 (1.6-4.4)	1.8 (1.1-2.8)	0.601
C-reactive protein, < 10 mg/L	5.0 (5.0-14.0)	5.0 (5.0-5.0)	5.0 (5.0-5.0)	0.541
Pancreatic amylase, 0.15-1.10 μcat/L	0.4 (0.3-0.7)	0.4 (0.3-0.5)	0.4 (0.3-0.6)	0.561
Procarboxypeptidase B, nmol/L	7.9 (5.4-16.3)	5.4 (3.5-7.4)	5.3 (3.0-9.5)	0.871
Trypsinogen-2, 30-110 μg/L	126.0 (83.0-208.4)	118.0 (86.3-132.6)	88.5 (68.6-142.3)	0.391

Data are expressed as mean ± SD or n (%).

¹Conventional endoscopic retrograde cholangiopancreatography (CV ERCP) vs rendezvous ERCP (RV ERCP);

²Laparoscopic cholecystectomy (LC) without ERCP. ASA: American Society of Anesthesiologists.